Stock Quotes & Company News | Reuters.com
Edition:
United States

People: CorMedix Inc (CRMD.K)

CRMD.K on American Stock Exchange

2.00USD
27 Jun 2016
Change (% chg)

$0.09 (+4.71%)
Prev Close
$1.91
Open
$1.87
Day's High
$2.02
Day's Low
$1.83
Volume
354,926
Avg. Vol
337,905
52-wk High
$4.78
52-wk Low
$1.15

Pfaffle, Antony 

Dr. Antony E. Pfaffle, M.D., Chief Scientific Officer and director of CorMedix Inc. Dr. Pfaffle has been a director of CorMedix since February 2007 and, effective January 1, 2013, became our Acting Chief Scientific Officer. Dr. Pfaffle has been Director of Healthcare Research at Bearing Circle Capital, L.P., an investment fund, since May 2007. Dr. Pfaffle is an Advisory Medical Director for ParagonRx, an Inventiv Company specializing in drug and device risk evaluation and mitigation. He was a Managing Director at Paramount BioCapital, Inc. and Senior Vice-President of Business Development at Paramount BioSciences, LLC from December 2005 to May 2007. Dr. Pfaffle was a Principal and Founder of Black Diamond Research, an investment research company, from July 2001 to December 2005. Dr. Pfaffle is an internist who practiced nephrology at New York Hospital-Weill Cornell Medical Center, Lenox Hill Hospital and Memorial Sloan-Kettering Cancer Center. Dr. Pfaffle received his M.D. from New York Medical College in 1989.

Basic Compensation

Total Annual Compensation, USD 249,800
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 373,478
Fiscal Year Total, USD 623,278

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --